# RCM Technologies, Inc.: financial statements, quarterly

RCMT · Nasdaq · CIK 700841 · [Industrials](/sectors/industrials.md) · fiscal year ends Jan 2

Pages: [Overview](/companies/rcmt.md) · [Financials](/companies/rcmt/financials.md) · [Filings](/companies/rcmt/filings.md) · [Insiders](/companies/rcmt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rcmt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2026-01-03) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [58.0](/filings/0001437749-24-033917.md) | [71.0 d](/filings/0001437749-25-010202.md) | [71.9](/filings/0001437749-25-015505.md) | [69.2](/filings/0001437749-25-025431.md) | [60.4](/filings/0001437749-25-033607.md) | [76.9 d](/filings/0001437749-26-011236.md) | [84.5](/filings/0001437749-26-017057.md) | [78.2](/filings/0001437749-26-027653.md) | [70.3](/filings/0001437749-25-033607.md) | [86.5 d](/filings/0001437749-26-011236.md) | [83.0](/filings/0001437749-26-017057.md) | [93.8](/filings/0001437749-26-027653.md) |
| Cost of revenue | $m | [40.8](/filings/0001437749-24-033917.md) | [49.4 d](/filings/0001437749-25-010202.md) | [51.6](/filings/0001437749-25-015505.md) | [49.2](/filings/0001437749-25-025431.md) | [42.5](/filings/0001437749-25-033607.md) | [55.3 d](/filings/0001437749-26-011236.md) | [62.5](/filings/0001437749-26-017057.md) | [55.9](/filings/0001437749-26-027653.md) | [50.9](/filings/0001437749-25-033607.md) | [62.2 d](/filings/0001437749-26-011236.md) | [61.0](/filings/0001437749-26-017057.md) | [69.7](/filings/0001437749-26-027653.md) |
| Gross profit | $m | [17.3](/filings/0001437749-24-033917.md) | [21.6 d](/filings/0001437749-25-010202.md) | [20.4](/filings/0001437749-25-015505.md) | [20.0](/filings/0001437749-25-025431.md) | [17.8](/filings/0001437749-25-033607.md) | [21.6 d](/filings/0001437749-26-011236.md) | [22.0](/filings/0001437749-26-017057.md) | [22.3](/filings/0001437749-26-027653.md) | [19.4](/filings/0001437749-25-033607.md) | [24.3 d](/filings/0001437749-26-011236.md) | [22.0](/filings/0001437749-26-017057.md) | [24.1](/filings/0001437749-26-027653.md) |
| Selling, general and administrative | $m | [12.7](/filings/0001437749-24-033917.md) | [13.4 d](/filings/0001437749-25-010202.md) | [14.2](/filings/0001437749-25-015505.md) | [13.5](/filings/0001437749-25-025431.md) | [13.0](/filings/0001437749-25-033607.md) | [16.0 d](/filings/0001437749-26-011236.md) | [15.0](/filings/0001437749-26-017057.md) | [15.3](/filings/0001437749-26-027653.md) | [14.9](/filings/0001437749-25-033607.md) | [15.8 d](/filings/0001437749-26-011236.md) | [15.5](/filings/0001437749-26-017057.md) | [15.6](/filings/0001437749-26-027653.md) |
| Operating income | $m | [4.3](/filings/0001437749-24-033917.md) | [7.9 d](/filings/0001437749-25-010202.md) | [5.8](/filings/0001437749-25-015505.md) | [5.8](/filings/0001437749-25-025431.md) | [4.4](/filings/0001437749-25-033607.md) | [6.3 d](/filings/0001437749-26-011236.md) | [6.6](/filings/0001437749-26-017057.md) | [6.6](/filings/0001437749-26-027653.md) | [3.9](/filings/0001437749-25-033607.md) | [8.0 d](/filings/0001437749-26-011236.md) | [5.9](/filings/0001437749-26-017057.md) | [8.0](/filings/0001437749-26-027653.md) |
| Income tax | $m | [0.4](/filings/0001437749-24-033917.md) | [2.1 d](/filings/0001437749-25-010202.md) | [1.5](/filings/0001437749-25-015505.md) | [1.5](/filings/0001437749-25-025431.md) | [1.0](/filings/0001437749-25-033607.md) | [2.9 d](/filings/0001437749-26-011236.md) | [1.7](/filings/0001437749-26-017057.md) | [1.9](/filings/0001437749-26-027653.md) | [1.1](/filings/0001437749-25-033607.md) | [1.1 d](/filings/0001437749-26-011236.md) | [1.5](/filings/0001437749-26-017057.md) | [2.3](/filings/0001437749-26-027653.md) |
| Net income | $m | [3.8](/filings/0001437749-24-033917.md) | [5.3 d](/filings/0001437749-25-010202.md) | [4.0](/filings/0001437749-25-033607.md) | [3.8](/filings/0001437749-25-033607.md) | [2.7](/filings/0001437749-25-033607.md) | [2.9 d](/filings/0001437749-26-011236.md) | [4.2](/filings/0001437749-26-027653.md) | [3.8](/filings/0001437749-26-027653.md) | [2.3](/filings/0001437749-25-033607.md) | [6.1 d](/filings/0001437749-26-011236.md) | [3.8](/filings/0001437749-26-027653.md) | [4.9](/filings/0001437749-26-027653.md) |
| Diluted EPS | $ per share | [0.46](/filings/0001437749-24-033917.md) | not reported | [0.48](/filings/0001437749-25-015505.md) | [0.47](/filings/0001437749-25-025431.md) | [0.35](/filings/0001437749-25-033607.md) | not reported | [0.54](/filings/0001437749-26-017057.md) | [0.50](/filings/0001437749-26-027653.md) | [0.30](/filings/0001437749-25-033607.md) | not reported | [0.52](/filings/0001437749-26-017057.md) | [0.68](/filings/0001437749-26-027653.md) |
| Basic EPS | $ per share | [0.47](/filings/0001437749-24-033917.md) | not reported | [0.50](/filings/0001437749-25-015505.md) | [0.48](/filings/0001437749-25-025431.md) | [0.36](/filings/0001437749-25-033607.md) | not reported | [0.55](/filings/0001437749-26-017057.md) | [0.51](/filings/0001437749-26-027653.md) | [0.30](/filings/0001437749-25-033607.md) | not reported | [0.53](/filings/0001437749-26-017057.md) | [0.69](/filings/0001437749-26-027653.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | FY2025 (2026-01-03) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.7](/filings/0001437749-23-031268.md) | [6.3](/filings/0001437749-25-010202.md) | [2.1](/filings/0001437749-24-015677.md) | [3.5](/filings/0001437749-24-025545.md) | [3.2](/filings/0001437749-24-033917.md) | [4.7](/filings/0001437749-26-011236.md) | [5.2](/filings/0001437749-25-015505.md) | [5.5](/filings/0001437749-25-025431.md) | [1.3](/filings/0001437749-25-033607.md) | [2.9](/filings/0001437749-26-027653.md) | [2.6](/filings/0001437749-26-017057.md) | [6.6](/filings/0001437749-26-027653.md) |
| Current assets | $m | [73.0](/filings/0001437749-23-031268.md) | [90.5](/filings/0001437749-25-010202.md) | [89.8](/filings/0001437749-24-015677.md) | [85.3](/filings/0001437749-24-025545.md) | [90.5](/filings/0001437749-24-033917.md) | [97.0](/filings/0001437749-26-011236.md) | [86.0](/filings/0001437749-25-015505.md) | [101](/filings/0001437749-25-025431.md) | [94.9](/filings/0001437749-25-033607.md) | [99.9](/filings/0001437749-26-027653.md) | [102](/filings/0001437749-26-017057.md) | [100](/filings/0001437749-26-027653.md) |
| Total assets | $m | [101](/filings/0001437749-24-033917.md) | [120](/filings/0001437749-25-010202.md) | [120](/filings/0001437749-25-015505.md) | [118](/filings/0001437749-25-025431.md) | [126](/filings/0001437749-25-033607.md) | [132](/filings/0001437749-26-011236.md) | [121](/filings/0001437749-26-017057.md) | [136](/filings/0001437749-26-027653.md) | [130](/filings/0001437749-25-033607.md) | [134](/filings/0001437749-26-027653.md) | [135](/filings/0001437749-26-017057.md) | [134](/filings/0001437749-26-027653.md) |
| Current liabilities | $m | not reported | [58.2](/filings/0001437749-25-007557.md) | [62.8](/filings/0001437749-24-015677.md) | [57.6](/filings/0001437749-24-025545.md) | [55.6](/filings/0001437749-24-033917.md) | [53.6](/filings/0001437749-26-011236.md) | [53.2](/filings/0001437749-25-015505.md) | [54.5](/filings/0001437749-25-025431.md) | [48.0](/filings/0001437749-25-033607.md) | [53.9](/filings/0001437749-26-027653.md) | [52.8](/filings/0001437749-26-017057.md) | [52.2](/filings/0001437749-26-027653.md) |
| Total liabilities | $m | [79.8](/filings/0001437749-23-031268.md) | [94.7](/filings/0001437749-25-007557.md) | [91.1](/filings/0001437749-24-015677.md) | [89.8](/filings/0001437749-24-025545.md) | [95.5](/filings/0001437749-24-033917.md) | [98.6](/filings/0001437749-26-011236.md) | [86.4](/filings/0001437749-25-015505.md) | [97.8](/filings/0001437749-25-025431.md) | [88.4](/filings/0001437749-25-033607.md) | [88.4](/filings/0001437749-26-027653.md) | [91.0](/filings/0001437749-26-017057.md) | [85.2](/filings/0001437749-26-027653.md) |
| Shareholders' equity | $m | [21.4](/filings/0001437749-24-033917.md) | [25.8](/filings/0001437749-26-011236.md) | [29.4](/filings/0001437749-25-033607.md) | [28.5](/filings/0001437749-25-033607.md) | [30.0](/filings/0001437749-25-033607.md) | [33.5](/filings/0001437749-26-027653.md) | [34.6](/filings/0001437749-26-027653.md) | [37.8](/filings/0001437749-26-027653.md) | [41.4](/filings/0001437749-25-033607.md) | [46.0](/filings/0001437749-26-027653.md) | [44.3](/filings/0001437749-26-027653.md) | [48.8](/filings/0001437749-26-027653.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2026-01-03) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [11.0 d](/filings/0001437749-24-033917.md) | [(15.1) d](/filings/0001437749-25-010202.md) | [6.4](/filings/0001437749-25-015505.md) | [5.7 d](/filings/0001437749-25-025431.md) | [(4.3) d](/filings/0001437749-25-033607.md) | [(1.6) d](/filings/0001437749-26-011236.md) | [16.7](/filings/0001437749-26-017057.md) | [(7.9) d](/filings/0001437749-26-027653.md) | [(1.3) d](/filings/0001437749-25-033607.md) | [11.4 d](/filings/0001437749-26-011236.md) | [2.7](/filings/0001437749-26-017057.md) | [10.9 d](/filings/0001437749-26-027653.md) |
| Capital expenditure | $m | [0.3 d](/filings/0001437749-24-033917.md) | [2.1 d](/filings/0001437749-25-010202.md) | [0.7](/filings/0001437749-25-015505.md) | [0.4 d](/filings/0001437749-25-025431.md) | [0.5 d](/filings/0001437749-25-033607.md) | [1.0 d](/filings/0001437749-26-011236.md) | [0.4](/filings/0001437749-26-017057.md) | [0.5 d](/filings/0001437749-26-027653.md) | [0.5 d](/filings/0001437749-25-033607.md) | [0.2 d](/filings/0001437749-26-011236.md) | [0.1](/filings/0001437749-26-017057.md) | [0.1 d](/filings/0001437749-26-027653.md) |
| Share repurchases | $m | [3.4 d](/filings/0001437749-24-033917.md) | [1.3 d](/filings/0001437749-25-010202.md) | [0.0](/filings/0001437749-25-015505.md) | [5.4 d](/filings/0001437749-25-025431.md) | [2.4 d](/filings/0001437749-25-033607.md) | [(0.0) d](/filings/0001437749-26-011236.md) | [3.2](/filings/0001437749-26-017057.md) | [1.9 d](/filings/0001437749-26-027653.md) | [0.0 d](/filings/0001437749-25-033607.md) | [2.2 d](/filings/0001437749-26-011236.md) | [6.7](/filings/0001437749-26-017057.md) | [(0.0) d](/filings/0001437749-26-027653.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-10-01) | Q1 FY2023 (2023-04-01) | Q2 FY2023 (2023-07-01) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [10.5](/filings/0001437749-23-031268.md) | [9.4](/filings/0001437749-23-013603.md) | [8.6](/filings/0001437749-24-025545.md) | [8.2](/filings/0001437749-24-033917.md) | [8.2](/filings/0001437749-25-015505.md) | [8.0](/filings/0001437749-25-025431.md) | [7.8](/filings/0001437749-25-033607.md) | [7.7](/filings/0001437749-26-017057.md) | [7.5](/filings/0001437749-26-027653.md) | [7.6](/filings/0001437749-25-033607.md) | [7.4](/filings/0001437749-26-017057.md) | [7.2](/filings/0001437749-26-027653.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 7,110,759 at 2026-08-12, from the cover of the [10-Q filed 2026-08-13](/filings/0001437749-26-027653.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.